0001127602-22-013055.txt : 20220503 0001127602-22-013055.hdr.sgml : 20220503 20220503165645 ACCESSION NUMBER: 0001127602-22-013055 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220502 FILED AS OF DATE: 20220503 DATE AS OF CHANGE: 20220503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cooke Shane CENTRAL INDEX KEY: 0001524823 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 22887968 MAIL ADDRESS: STREET 1: TREASURY BUILDING LOWER GRAND CANAL ST. CITY: DUBLIN 2 STATE: L2 ZIP: 00000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-05-02 0001520262 Alkermes plc. ALKS 0001524823 Cooke Shane CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 Ireland 1 Ordinary Shares 2022-05-02 4 M 0 10000 16.55 A 100478 D Ordinary Shares 2022-05-02 4 S 0 10000 29.233 D 90478 D Employee Stock Option (Right to Buy) 16.55 2022-05-02 4 M 0 10000 0 D 2022-05-21 Ordinary Shares 10000 0 D This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.79 to $29.50. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. These options are fully vested in accordance with their terms. /s/ Shantale Greenson, attorney-in-fact for Shane Cooke 2022-05-03